196 related articles for article (PubMed ID: 29771426)
41. Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study.
Kumar SI; Kumar A; Srivastava S; Saraswat VA; Aggarwal R
Indian J Gastroenterol; 2005; 24(5):211-5. PubMed ID: 16361766
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of the factor V Leiden mutation in portal and hepatic vein thrombosis.
Das R; Garewal G; Chawla Y; Dhiman RK
Gut; 1998 Jul; 43(1):147. PubMed ID: 9771422
[No Abstract] [Full Text] [Related]
43. Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients.
Abdel Ghaffar TY; Elsayed SM; Sakr MA; Elsobky ES; Abdelhakam SM; Yousuf S; Eğin Y; Akar N
Turk J Haematol; 2011 Dec; 28(4):299-305. PubMed ID: 27264587
[TBL] [Abstract][Full Text] [Related]
44. Multiple thrombophilic factors in a patient with Budd-Chiari syndrome.
Brancaccio V; Iannaccone L; Margaglione M; Guardascione MA; Amitrano L
Clin Lab Haematol; 2002 Feb; 24(1):61-3. PubMed ID: 11843901
[TBL] [Abstract][Full Text] [Related]
45. Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability.
Minnema MC; Janssen HL; Niermeijer P; de Man RA
J Hepatol; 2000 Sep; 33(3):509-12. PubMed ID: 11020010
[TBL] [Abstract][Full Text] [Related]
46. Subacute Budd-Chiari syndrome associated with polycythemia vera and factor V Leiden mutation.
Simsek S; Verheesen RV; Haagsma EB; Lourens J
Neth J Med; 2000 Aug; 57(2):62-7. PubMed ID: 10924943
[TBL] [Abstract][Full Text] [Related]
47. Budd-Chiari syndrome with underlying homozygous factor V Leiden and heterozygous methylenetetrahydrofolate reductase mutations.
Barada KA; Azar CR; Otrock ZK; Taher AT
J Gastroenterol; 2005 Oct; 40(10):1002-3. PubMed ID: 16261441
[No Abstract] [Full Text] [Related]
48. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.
He FL; Wang L; Zhao HW; Fan ZH; Zhao MF; Dai S; Yue ZD; Liu FQ
World J Gastroenterol; 2015 Feb; 21(8):2413-8. PubMed ID: 25741149
[TBL] [Abstract][Full Text] [Related]
49. [Apoptosis of pathological tissues and expression of apoptosis-related genes in hepatic venous stricture Budd-Chiari syndrome].
Wang CX; Huang ZQ; Liang FQ; Li R; Peng Z
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):912-5. PubMed ID: 16029531
[TBL] [Abstract][Full Text] [Related]
50. JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation.
Plumé G; Vayá A; Ferrando F; Mira Y; Orbis F
Thromb Haemost; 2007 Sep; 98(3):681-2. PubMed ID: 17849060
[No Abstract] [Full Text] [Related]
51. Budd-Chiari Syndrome and antithrombin III deficiency.
McClure S; Dincsoy HP; Glueck H
Am J Clin Pathol; 1982 Aug; 78(2):236-41. PubMed ID: 7102823
[TBL] [Abstract][Full Text] [Related]
52. [Budd-Chiari syndrome in children and adolescents: therapeutic radiological intervention].
Wang L; Zu MH; Gu YM; Xu H; Zhang QQ; Wei N; Xu W; Cui YF; Teng F; Hua QJ
Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):590-4. PubMed ID: 24225289
[TBL] [Abstract][Full Text] [Related]
53. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
[TBL] [Abstract][Full Text] [Related]
54. Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis.
Denninger MH; Helley D; Valla D; Guillin MC
Thromb Haemost; 1997 Oct; 78(4):1297-8. PubMed ID: 9365003
[No Abstract] [Full Text] [Related]
55. Factor V leiden mutation and Budd-Chiari syndrome.
Mohanty D; Shetty S; Narayanan TS; Abraham P
Blood; 1998 Sep; 92(5):1838-9. PubMed ID: 9716618
[No Abstract] [Full Text] [Related]
56. A Nationwide Analysis of Budd-Chiari Syndrome in the United States.
Alukal JJ; Zhang T; Thuluvath PJ
J Clin Exp Hepatol; 2021; 11(2):181-187. PubMed ID: 33746442
[TBL] [Abstract][Full Text] [Related]
57. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature.
Dilawari JB; Bambery P; Chawla Y; Kaur U; Bhusnurmath SR; Malhotra HS; Sood GK; Mitra SK; Khanna SK; Walia BS
Medicine (Baltimore); 1994 Jan; 73(1):21-36. PubMed ID: 8309360
[TBL] [Abstract][Full Text] [Related]
58. Acquired and Heritable Thrombophilia in Indian Patients With Pediatric Deep Venous Thrombosis (DVT).
Pai N; Ghosh K; Shetty S
Clin Appl Thromb Hemost; 2014 Sep; 20(6):573-6. PubMed ID: 23406614
[TBL] [Abstract][Full Text] [Related]
59. Budd-Chiari syndrome associated with homozygous factor V Leiden mutation.
Garewal G; Das R; Chawla Y; Dhiman RK
Br J Haematol; 1999 Jun; 105(3):842. PubMed ID: 10354159
[No Abstract] [Full Text] [Related]
60. Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
Delahousse B; Iochmann S; Pouplard C; Fimbel B; Charbonnier B; Gruel Y
Blood Coagul Fibrinolysis; 1997 Nov; 8(8):503-9. PubMed ID: 9491268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
